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Solution Structure of the CIDE-N Domain of CIDE-B
and a Model for CIDE-N/CIDE-N Interactions
in the DNA Fragmentation Pathway of Apoptosis
9, respectively. These activated initiator caspases, in
turn, actuate the downstream executioner Caspases 3,
6, and 7 (Zou et al., 1997; Green, 1998). The cross-talk
between the two pathways is mediated by BID, which
upon cleavage by Caspase 8, can activate the mitochon-
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triggered by a heterodimeric protein composed of a 40³Laboratory for Apoptosis Regulation
kDa caspase-activated DNA fragmentation factor (DFF40/Institute of Molecular and Cell Biology
CAD) and its 45 kDa inhibitor (DFF45/ICAD) (Liu et al.,30 Medical Drive
1997; Enari et al., 1998). Cleavage of DFF45/ICAD bySingapore 117609
Caspase 3 at two different sites releases DFF40/CADSingapore
from the complex and triggers DNA fragmentation and
nuclear condensation (Liu et al., 1998; Sakahira et al.,
1998). DFF40/CAD consists of two domains with distinctSummary
functions. Its C-terminal part exhibits DNA nuclease ac-
tivity, whereas the N-terminal CIDE-N domain has a reg-Apoptotic DNA fragmentation and chromatin conden-
ulatory function (Inohara et al., 1999). Similarly, DFF45/sation are mediated by the caspase-activated DFF40/
ICAD contains an N-terminal CIDE-N domain (Figure 1A)CAD nuclease, which is chaperoned and inhibited by
that is sufficient to inhibit DNA fragmentation (InoharaDFF45/ICAD. CIDE proteins share a homologous regu-
et al., 1998). Additionally, CIDE-N of DFF45 exhibitslatory CIDE-N domain with DFF40/CAD and DFF45/
chaperone activity on DFF40 by directly interacting withICAD. Here we report the solution structure of CIDE-N
CIDE-N of DFF40 (McCarty et al., 1999a, 1999b), albeitof human CIDE-B. We show that the CIDE-N of CIDE-B
other domains of DFF45 are required for its effective chap-interacts with CIDE-N domains of both DFF40 and
erone function (Gu et al., 1999; Sakahira et al., 1999).DFF45. The binding epitopes are similar and map to
Recently, a novel family of cell death±inducing DFF45-a highly charged bipolar surface region of CIDE-B.
like effector (CIDE) proteins has been identified (InoharaFurthermore, we demonstrate that the CIDE-N of
et al., 1998). CIDEs share an N-terminal domain that isCIDE-B regulates enzymatic activity of the DFF40/
homologous to the CIDE-Ns of DFF40/CAD and DFF45/DFF45 complex in vitro. Based on these results and
ICAD (Figure 1A). It has been shown that overexpressionmutagenesis data, we propose a model for the CIDE-N/
of CIDEs results in apoptosis (Inohara et al., 1998). UnlikeCIDE-N complex and discuss the role of this novel
DFF45 and DFF40, CIDE proteins are expressed in abipolar interaction in mediating downstream events of
highly restricted manner and show pronounced tissueapoptosis.
specificity (Inohara et al., 1998). Besides the N-terminal
domain (CIDE-N), CIDEs also contain a C-terminal killer
Introduction domain (CIDE-C) (Figure 1B). Interestingly, while the pro-
apoptotic function of full-length CIDEs is inhibited by
Apoptosis, a morphologically distinct form of pro- DFF45, CIDE-C domains can induce apoptosis even in
grammed cell death, is an evolutionary highly conserved the presence of DFF45. Thus, it has been postulated
phenomenon that plays an important role in the regula- that CIDE-N domains play a regulatory role in mediating
tion of cellular activities in eukaryotes (Wylie et al., 1980). CIDE-induced apoptosis by associating with other
Various stimuli, such as cytokines and anticancer drugs, CIDE-N domain-containing proteins. However, no direct
as well as growth factor deprivation and radiation dam- evidence for that interaction has been reported (Inohara
age, cause a cell to undergo a rapid, inflammatory-free et al., 1998).
clearance that is characterized by cell shrinkage, bleb- The high degree of homology among the N-terminal
bing of plasma membranes, nuclear condensation, and regions of DFF40, DFF45, and CIDEs (Figure 1A) sug-
DNA fragmentation (Earnshaw, 1995; Nagata, 1997; gests a common regulatory role of CIDE-N domains in
Green and Reed, 1998). Apoptosis consists of two the DNA fragmentation pathway of apoptosis. To under-
stages: the stage of the commitment, when the target stand the molecular basis for CIDE-N function, we deter-
cell is being sentenced to death; and the stage of execu- mined the solution structure of CIDE-N of human CIDE-B
(Figures 2A and 2B). The structure consists of a twistedtion, when proteins, DNA, and other structural compo-
five-stranded b sheet and two a helices arranged innents of the cell are destroyed. Death signals originating
an a/b roll fold. Using NMR titration experiments, wefrom the death receptors, such as TNF and Fas, or mito-
showed that the CIDE-N of CIDE-B interacts with thechondria trigger the activation of Caspase 8 or Caspase
CIDE-N domains of DFF45 and DFF40. Based on the
chemical shift perturbation data, we mapped the binding§ To whom correspondence should be addressed (e-mail: gerhard_
surface of CIDE-N (CIDE-B) to the solvent-exposed facewagner@hms.harvard.edu).
‖ These authors contributed equally to this work. of the b sheet and a conserved EDG loop located on
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Figure 1. Amino Acid Sequences of the CIDE Family Proteins
(A) Sequence alignment of different CIDE-N domains. The conserved and homologous residues are shown in black and gray, respectively.
The secondary structure of the CIDE-N of CIDE-B is presented on the top; cylinders and arrows represent a helices and b strands, respectively.
The residues of the CIDE-N domain of CIDE-B, which are perturbed upon binding to the CIDE-N domain of DFF45, are illustrated with asterisks.
(B) Functional domains of CIDE-B protein. CIDE-N and CIDE-C domains are shown in gray and black, respectively.
the same side of the molecule. This binding surface is three pairs of triple resonance experiments [HNCA,
HN(CO)CA, HNCO, HN(CA)CO, HN(CA)CB, HN(COCA)highly polar and consists of two oppositely charged
regions. The unusual juxtaposition of the large basic CB], 15N selective labeling of valine, leucine, and isoleu-
cine, and reverse labeling of arginine residues as de-and acidic surfaces suggests a bipolar electrostatic
mode for the CIDE-N/CIDE-N homophilic interaction. scribed before (Chou et al., 1998). The structure of the
CIDE-N of CIDE-B was determined using a total of 1206Additionally, CIDE-N (CIDE-B) can regulate the enzy-
matic activity of the DFF40/DFF45 complex, as shown distance constraints derived from 2D homonuclear
NOESY and 3D 15N or 13C dispersed NOESY experimentsby an in vitro DNA degradation assay. This further sup-
ports the significance of the CIDE-N homophilic interac- and 210 angle constraints derived from the analysis of
local NOE patterns and 3JNa scalar coupling constants,tion. Finally, based on the structure of CIDE-N domains,
together with the chemical shift perturbation and muta- measured in an HMQC-J experiment. Residues 1±31
and 111±122 were found to be unstructured based ongenesis data, we propose a novel mechanism for the
CIDE-N/CIDE-N homophilic association, which involves transverse 15N relaxation rates (data not shown) and the
absence of long-range NOEs in these regions. Struc-complementary neutralization of two bipolar surfaces.
tures were calculated with a combined use of torsion
angle dynamics (GuÈ ntert et al., 1997) and simulated an-Results and Discussion
nealing (BruÈ nger, 1994). The quality of the determined
structures can be assessed from the structural statisticsStructure Determination
Sequential resonance assignments of the CIDE-N do- of the ensemble of 15 calculated structures (Table 1 and
Figure 2A).main of CIDE-B (residues 1±116) were achieved using
Figure 2. Solution Structure of the CIDE-N Domain of CIDE-B
(A) Stereo view of the backbone atoms (N, Ca, CO) of the 15 superimposed NMR-derived structures of CIDE-N (CIDE-B) (residues 34±109). b
strands and a helices are shown in blue and red, respectively.
(B) The ribbon diagram of CIDE-N (CIDE-B) (residues 34±109).
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The CIDE-N Domain of CIDE-B Binds DFF40Table 1. Structural Statistics for the CIDE-N of CIDE-B
and DFF45 CIDE-N Domains
NOE distance restraints Previously, association between CIDE-N domains of
All 1120 DFF40 and DFF45 has been observed (McCarty et al.,
Intraresidue 755
1999a, 1999b), and interaction between CIDE-N of CIDE-ASequential (|i 2 j| 5 1) 194
and DFF45 has been postulated (Inohara et al., 1998).Medium range (|i 2 j| # 4) 45
Thus, we explored the possibility of the interaction be-i, i 1 2 11
i, i 1 3 24 tween CIDE-N (CIDE-B) and the homologous domains
i, i 1 4 10 of DFF40 and DFF45. We performed titration experi-
Long range (|i 2 j| $ 5) 116 ments by recording 1H-15N HSQC spectra of 15N-labeled
H bond constraintsa 96
CIDE-N (CIDE-B) in the presence of an excess of unla-Dihedral angle constraintsb 210
beled CIDE-N domains of DFF40 and DFF45. Interest-Ramachandran plotc
ingly, we found that CIDE-Ns of both DFF40 and DFF45Most favorable region 83.4%
Additionally allows region 16.6% bind to the same face of the CIDE-N domain of CIDE-B.
Generously allowed region 0.0% Resonances of residues 39±55, 78±81, 87, 91, 96±97,
Disallowed region 0.0% 99±101, and 105 were perturbed upon binding of either
Average ensemble rmsdd CIDE-N (DFF40) or CIDE-N (DFF45) (Figure 3D). In addi-Backbone (residues 35±108) 0.73 AÊ
tion, residue 36 was affected in the titration with CIDE-NHeavy atoms (residues 35±108) 1.29 AÊ
(DFF45), but not with CIDE-N (DFF40), indicating a
a Hydrogen bonds were added only at the late stage of structural slight difference in the location and size of the binding
calculations for residues with characteristic NOE patterns.
face. The analysis of the perturbation patterns revealedb Dihedral angle constraints were generated using DYANA (GuÈ ntert
that residues in strands 1 and 2 (residues 36, 39±55)et al., 1997) based on 3JaN couplings and NOE constraints.
and the conserved loop residues 78±81 and 96±97 arec PROCHECK_NMR (Laskowski et al. 1996) was used to assess the
quality of the structures. affected most, and thus they constitute the bulk of the
d None of these structures exhibit distance violations greater than interaction interface. Residues 87, 91, and 105 are adja-
0.2 AÊ or dihedral angle violations greater than 58. cent but peripheral to the main binding face. It is possi-
ble that these residues located in the loop regions expe-
rience long-range effects. Perturbations in strand 5Structure Overview
(residues 99±102) may represent a secondary effect, asThe three-dimensional structure of the CIDE-N of CIDE-B
strand 5 pairs with strand 1, which is involved in theis shown in Figure 2B. Regions 1±31 and 111±122 are
interaction. The perturbation pattern suggests thatomitted because they are largely disordered. The struc-
some local rearrangements occur upon binding; how-tured portion of the CIDE-N domain of CIDE-B has the
ever, the overall structural integrity is preserved, as thefold of an a/b roll and consists of five b strands arranged
only residues affected outside of strands 1, 2, and 5in a single sheet and two a helices (Figure 1A). Strand
are located in loop regions, and the resonances of the1 (residues 35±42) and strand 2 (residues 47±54) are
residues involved in the hydrophobic core formation
connected by a short constrained loop (residues 43±46)
remain unchanged.
and form a b hairpin. Helix 1 (residues 58±68) is packed
The analysis of the interaction surface of CIDE-N
against strands 3 (residues 74±77), 4 (residues 82±85), (CIDE-B) with CIDE-N domains of DFF40 and DFF45
and 5 (residues 99±102), which are arranged in an anti- (Figures 3A and 3B) shows that the perturbed residues
parallel orientation. Strand 5 and a portion of strand 1 are localized on one side of the molecule and are clus-
(residues 39±42) pair in a parallel orientation and com- tered into two regions. The bottom region in the orienta-
plete the assembly of the mixed b sheet. The structure tion of Figure 3A encompasses strands 1 and 2 (residues
is additionally stabilized by the packing of aromatic resi- 36, 39±53), and the top region includes residues 78±81
dues in the core of the domain. Phenylalanines 38, 89, and 96±97. Interestingly, these two regions coincide with
and 90 are integrated into the hydrophobic core of the two areas of opposite charge in an electrostatic surface
molecule, whereas tryptophane 108 constrains the C-ter- plot (Figure 4A), suggesting a possibility of an electro-
minal loop (residues 103±108) by contacting valine 76, static mode for the CIDE-N/CIDE-N interaction.
alanine 83, and methionine 100 of strands 3 and 5. Aro-
matic residues in positions 90 and 108 are absolutely CIDE-N (CIDE-B) Can Regulate the Enzymatic
conserved within the CIDE family, and corresponding Activity of the DFF40/DFF45 Complex
mutations in DFF40 resulted in the diminished nuclease DFF45 efficiently inhibits DFF40 nuclease activity
activity of the enzyme (Inohara et al., 1999). through the collective high-affinity binding of its multiple
A search using the DALI server (Holm and Sander, domains to DFF40 (McCarty et al., 1999a, 1999b ). Inhibi-
1993) revealed a similarity of the CIDE-N domain of tion, however, can be achieved by the independent bind-
CIDE-B to the Ras-binding domain (RBD) of Raf-1 kinase ing of the CIDE-N domain of DFF45 to the regulatory
(Protein Data Bank ID code 1c1y-B) with a Z score of domain of DFF40 at stoichiometric excess (McCarty et
2.7, although no sequence similarity exists between the al., 1999a, 1999b). We used an in vitro plasmid degrada-
proteins. Both molecules have an a/b roll type of fold tion assay to investigate the effect of CIDE-N (CIDE-B)
with an average rms deviation of 3.4 AÊ between superim- domain on the interaction of DFF40/DFF45 CIDE-N do-
posed backbone atoms. The RBD fold has also been mains. In this assay, full-length DFF40 was incubated
classified as a ubiquitin fold (Nassar et al., 1995); how- with plasmid DNA in the presence of different amounts
ever, the DALI search did not identify ubiquitin as a fold of CIDE-N (DFF45) and CIDE-N (CIDE-B), and the cleav-
age products were analyzed by gel electrophoresis onrelated to the CIDE-N domain of CIDE-B.
Cell
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Figure 3. CIDE-N (CIDE-B) Interacts with CIDE-N Domains of Both DFF40 and DFF45
(A) Ribbon diagram of CIDE-N (CIDE-B) is presented in two views different by 1808 rotation around the y axis.
(B) Surface plot of CIDE-N (CIDE-B). The amides involved in the interaction with both DFF40 and DFF45 are colored in blue; amide of residue
36 additionally involved in binding of DFF45 is colored in green. Orientation and views are the same as in (A).
(C) In vitro plasmid degradation assay. CIDE-N (CIDE-B) does not significantly affect the nuclease activity of DFF40, but it reverses the
inhibition of DFF40 by the CIDE-N domain of DFF45. DFF40 cleaves supercoiled plasmid (lane 1) into ca. 80 bp fragments (lane 2). This activity
is strongly inhibited by the CIDE-N domain of DFF45 (lane 3). Increasing concentrations of the CIDE-N of CIDE-B (lanes 4±9) reverse the
inhibition of DFF40 by the CIDE-N domain of DFF45. High concentrations of the CIDE-N domain of CIDE-B, however, did not significantly
inhibit DFF40 nuclease activity (lane 10). CIDE-N domains of neither DFF45 nor CIDE-B exhibit activity under these conditions (lanes 11
and 12).
(D) Overlay of 1H-15N HSQC spectra of 15N-labeled CIDE-N (CIDE-B) in absence (shown in black) and presence (shown in red) of the excess
of the unlabeled CIDE-N domain of DFF45.
2% agarose gels (Figure 3C). In contrast to the strong CIDE-N (DFF45) were calculated using the program
package Look (Levitt, 1995). The average structuresinhibition observed for the CIDE-N domain of DFF45,
the CIDE-N of CIDE-B had little effect. However, it was were then subjected to energy minimization using the
program ENCAD (Levitt, 1983) to ensure the correct ste-able to rescue the enzymatic activity of DFF40 pre-
viously inhibited by CIDE-N (DFF45). Combined with the reochemistry and the absence of van der Waals dis-
tances violations. The resulting models of CIDE-Nresults of NMR binding studies, this indicates that
CIDE-N (CIDE-B) is capable of sequestering CIDE-N (DFF40) and CIDE-N (DFF45) were similar to CIDE-N
(CIDE-B), and they exhibited a similar surface charge(DFF45) from the regulatory domain of DFF40, thus re-
storing the nuclease function. The opposite effects of polarity on the face similar to the binding interface of
the CIDE-N of CIDE-B (Figures 4B and 4C). Interestingly,CIDE-N domains of DFF45 and CIDE-B on DFF40 enzy-
matic activity may originate from their distinct surface in all three CIDE-Ns, the positively charged area has a
convex shape, whereas the negatively charged part isproperties and different on/off rates in CIDE-N/CIDE-N
complexes (discussed below). Our observations verify concave, which further supports our hypothesis that
CIDE-N domains interaction is electrostatically driven.the interaction between CIDE-B and the DFF40/DFF45
complex and raise the possibility that multiple pathways The tight fit between oppositely charged surfaces of
complementary shape would increase the interactionexist in regulation of DNA fragmentation in apoptosis.
strength, since it will eliminate the water molecules from
the interface.Modeling of DFF40 and DFF45 CIDE-N Domains
and the CIDE-N/CIDE-N Interaction To validate our modeling results, we obtained the
backbone resonance assignments of CIDE-N (DFF40)To further elucidate the mechanism of the CIDE-N/
CIDE-N interaction, we modeled the structures of CIDE-N and performed titrations experiments by recording 1H-15N
HSQC spectra of 15N-labeled CIDE-N (DFF40) in thedomains of DFF40 and DFF45. Since the CIDE-N do-
mains are 60% homologous (Figure 1A), it is possible presence of various concentrations of unlabeled CIDE-N
domains of DFF45 and CIDE-B (data not shown). Theto employ the segment matching method (Levitt, 1992)
using the backbone of CIDE-N (CIDE-B) as a framework established interaction interfaces of CIDE-N (DFF40)
with both CIDE-N (DFF45) and CIDE-N (CIDE-B) encom-to model CIDE-N domains of DFF40 and DFF45. We
followed the procedure described in Chou et al (1998). pass the bipolar region and are similar to the interaction
interfaces obtained for CIDE-N (CIDE-B).Twenty target structures of CIDE-N (DFF40) and of
CIDE-N Domain Structure and Interactions
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Figure 4. The Binding Face of CIDE-N Do-
main Possesses a Distinct Polarity with Two
Clusters of Opposite Charge Located on the
Same Side of the Molecule
(A) Electrostatic potential map of CIDE-N
(CIDE-B). Regions of negative and positive
charge are shown in red and blue, respec-
tively. Orientation and views are similar to Fig-
ure 3A.
(B) Electrostatic potential map of CIDE-N
(DFF45). Regions of negative and positive
charge are shown in red and blue, respec-
tively. Orientation and views are similar to Fig-
ure 3A.
(C) Electrostatic potential map of CIDE-N
(DFF40). Regions of negative and positive
charge are shown in red and blue, respec-
tively. Orientation and views are similar to Fig-
ure 3A.
Using the knowledge of the electrostatic properties (e.g., CIDE-N domains of DFF45 and DFF40) will interact
in a similar fashion (Figure 5).of CIDE-N domains and the maps of the interaction
surfaces, we constructed a model of CIDE-N (DFF45) in
complex with CIDE-N (CIDE-B). In our procedure, we Specificity of the CIDE-N/CIDE-N Interactions
Multiple lines of biochemical evidence suggest thataligned the molecules in a way that involves comple-
mentary neutralization of two bipolar surfaces and maxi- CIDE-N domains from different proteins interact with
each other. CIDE-Ns of DFF40 and DFF45 were shownmizes their surface complementarity. The resulting
model of the CIDE-N/CIDE-N complex obtained in this to interact (Inohara et al., 1999; McCarty et al., 1999a,
1999b). In our study, we have demonstrated the bindingway is presented on Figure 5. CIDE-N domains of
CIDE-B and DFF45 are arranged in a yin/yang-like con- of the CIDE-N of CIDE-B to the CIDE-N domains of
DFF45 and DFF40. Additionally, an interaction betweenfiguration so that the acidic (EDG loop) and basic
(strands 1 and 2) surfaces of the opposite domains con- CIDE-A and CIDE-B has been observed (P. L., unpub-
lished data). We have demonstrated that two clusterstact each other. The bipolar mode of the electrostatic
interaction is compatible with the surface properties of of oppositely charged residues located on the same
side of the protein are involved in the formation of thethe molecules as the convex positively charged area is
accommodated into the negatively charged pocket. The CIDE-N/CIDE-N complex. Given our modeling results
and conservation of the positively and negativelyelectrostatic nature of the interaction is consistent with
a relatively low affinity (KD in mM range) and relatively charged residue patterns within the CIDE-N family, we
suggest that the CIDE-N/CIDE-N interaction is driven byfast on/off rates of the CIDE-N/CIDE-N interaction
(McCarty et al., 1999a, 1999b). This is similar to the electrostatic forces. However, affinities vary for different
CIDE-N/CIDE-N complexes, such as DFF40/DFF45,characteristics found for other interactions dominated
by electrostatic component, such as the CD2/CD58 in- DFF45/CIDE-B, and DFF40/CIDE-B (P. L., unpublished
data). Comparison between CIDE-N domains of DFF40,teraction (Sun et al., 1999; Wang et al., 1999) or the
CARD/CARD interaction (Chou et al., 1998; Qin et al., DFF45, and CIDE-B revealed their various surface prop-
erties. We suggest that different degrees of surface and1999; Zhou et al., 1999). Based on the high degree of
sequence homology within CIDE family and preserved charge complementarity can modulate the propensities
for association, thus providing the fine-tuning of thesurface polarity, we propose that other CIDE-N domains
Cell
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Figure 5. A Model for the CIDE-N/CIDE-N
Homophilic Interaction
CIDE-N domains associate in a yin/yang-like
orientation with the EDG face of one molecule
packing against strands 1 and 2 of the other
one. Regions of positive and negative charge
are shown in blue and red, respectively. The
1808 rotation operations to form the putative
complexes are indicated with arrows. The
dashed line represents a weaker interaction
between CIDE-N domains of CIDE-B and
DFF40.
bipolar interaction in CIDE-N/CIDE-N complexes. This of CIDE-induced apoptosis (Inohara et al., 1998, 1999;
McCarty et al., 1999a, 1999b). This data combined withnotion may explain different effects of CIDE-N domains
of DFF45 and CIDE-B on the function of DFF40. The an observation of fast on/off rates for CIDE-N/CIDE-N
interactions (McCarty et al., 1999a, 1999b) suggest thatCIDE-N/CIDE-N interaction between DFF40 and CIDE-B
is weaker than those between DFF45 and CIDE-B or CIDE-Ns can generally act as ªbaitº domains providing
initial low-affinity recognition, whereas tight and specificDFF40 and DFF45. Thus, even in the presence of CIDE-N
(CIDE-B), the regulatory and catalytic domains of DFF40 binding originates from a slow association of multiple
ªanchorº domains.can associate and trigger the nuclease activity, whereas
CIDE-N (DFF45) would inhibit the enzyme.
On the functional level, the binding specificity of CIDE Comparison of CIDE-N/CIDE-N Interaction to Other
family proteins may come from synergistic interactions Homophilic Interaction in Apoptosis
between multiple protein domains. It has been reported
So far, three classes of homophilic interactions relevant
that the C-terminal domain of DFF45 binds the catalytic
for regulation of apoptosis have been described (Hof-
domain of DFF40 (Gu et al., 1999; McCarty et al., 1999a,
mann et al., 1997). The death domain (DD), death effector
1999b; Sakahira et al., 1999). On the other hand, CIDE-N
domain (DED), and caspase recruitment domain (CARD)
domains were shown to be essential for enzymatic activ-
are involved in the regulation of early events in apoptosis
ity of DFF40, chaperone activity of DFF45, and regulation
(reviewed by Liang and Fesik, 1997; Nagata, 1997).
Three-dimensional structures of several of these do-
mains have been determined (Huang et al., 1996; Chou
et al., 1998; Eberstadt et al., 1998). DD, DED, and CARD
are composed of six closely packed antiparallel a heli-
ces, and their surfaces have distinct electrostatic polari-
ties. DD/DD, DED/DED, and CARD/CARD interactions
are very selective, as any particular domain interacts
only with its partner, but not with other members of the
family. Electrostatic interactions have been implicated to
provide both driving force and specificity filters for DED/
DED and CARD/CARD interactions. Similarly CIDE-N/
CIDE-N interactions have electrostatic character, but
their specificity is limited, which can be representative
of their deployment in the execution process rather than
Figure 6. Point Mutations E50A and D51A Lead to the Diminished in initiation stage of apoptosis. Another difference be-
Enzymatic Activity of DFF40 in a Cell-Free System tween these homophilic interaction domains is the sur-
Constant concentrations of plasmid DNA (0.1 mg/ml) are treated with face charge distribution: DED and CARD have two oppo-
a series of 2-fold dilutions of WT-DFF40 (lane 1±6), E50A-DFF40 (lane sitely charged surfaces, whereas both positive and
7±12), and D51A-DFF40 (lane 13±18), respectively, in the absence of
negative charge clusters of CIDE-N are located on theDFF45. The concentrations of the enzyme were carefully normalized
same side of the molecule, making another face avail-by Western blotting. The experiment was performed similarly to the
plasmid degradation assay (described in Experimental Procedures). able for additional function. These observations suggest
CIDE-N Domain Structure and Interactions
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Figure 7. A Model for the Inhibition and Acti-
vation of DFF40 Nuclease
Caspase 3 cleaves DFF45 into three domains
that dissociate from the DFF40/DFF45 com-
plex (top). Subsequently, the EDG loop of the
CIDE-N domain of DFF40 interacts with the
catalytic domain of nuclease, triggering DNA
degradation and chromatin condensation.
DFF40 can be inhibited by an excess of
CIDE-N (DFF45). However, excess CIDE-N
(CIDE-B) can sequester the CIDE-N domain
of DFF45, making the EDG loop of DFF40
available for the interaction with nuclease
catalytic domain (bottom).
that the CIDE-N/CIDE-N interaction is a novel type of show the diminished nuclease activity, which cannot
be attributed to any additional factors interacting withhomophilic interaction involved in the regulation of apo-
ptosis. DFF40. Therefore, it results from the disrupted self-
assembly of DFF40. The backbone resonance assign-
ment of the CIDE-N (DFF40) reveals that E50 and D51Multiple Roles of the CIDE-N Domain
in DFF40 Nuclease are located in the loop region, so it is unlikely that the
mutagenesis altered the structure and the stability ofThe structural information allowed us to rationalize the
mutagenesis data available for the conserved residues the protein. It has been hypothesized (Inohara et al.,
1999) that the CIDE-N domain of DFF40 can act as anof the CIDE-N domain of DFF40. Substitutions K32A,
L48P, and T53L have no effect on the enzymatic func- activator domain for the nuclease. Our results indicate
that residues of the conserved EDG loop are importanttion, whereas mutations E50A, D51A, G52I, F60S, and
W78C (in the numbering of human DFF40 as in Figure for the enzymatic activity, possibly by being involved
in direct interaction between regulatory and catalytic1A) result in the diminished nuclease activity (Inohara
et al., 1999; P. L., unpublished data). Lysine 32 (located domains of DFF40.
The model for DFF40 activation is shown in Figurein the helix 1) is remote to the interaction interface and
has no obvious function. Leucine 48 and threonine 53 are 7. Full-length DFF45 inhibits DFF40 by the synergistic
binding of its three domains to both activator and cata-terminal residues of strands 3 and 4. The hydrophobic
contacts of their side chains are important for the con- lytic domains of the nuclease. Caspase 3 cleaves DFF45
into three individual domains, which dissociate awaystraining of the conserved EDG loop. Thus, mutations
preserving the hydrophobicity of these residues may from DFF40. The N-terminal domain of DFF45 binds
the activator domain of DFF40 and is sufficient for thenot affect the nuclease activity.
The conserved aromatic residues phenylalanine 60 inhibition; however, due to the competition with the cat-
alytic domain of the nuclease, an excess of CIDE-Nand tryptophane 78 are involved in the formation of the
hydrophobic core of the molecule; therefore, mutations (DFF45) is required. The CIDE-N domain of CIDE-B can
sequester CIDE-N (DFF45) and thus is able to rescuein these positions can reduce the enzyme stability. Gly-
cine 52 adopts a conformation with positive φ angle, the nuclease activity. The observation that the mutations
in the EDG loop reduce nuclease activity in the absencewhich is not readily accessible for isoleucine. Thus, the
G52I mutation may alter the conformation of the nega- of DFF45 suggests that the EDG loop of CIDE-N (DFF40)
interacts with the catalytic domain of the nuclease (Fig-tively charged EDG loop, which is important for CIDE-N/
CIDE-N interactions. ure 7).
Thus, the CIDE-N domain of DFF40 has multiple func-An interesting observation comes from the analysis
of the E50A and D51A mutants. Glutamate 50 and aspar- tions. In the absence of apoptotic stimuli, it is recognized
by DFF45 for chaperoning and inhibition purposes. Ontate 51 are located on the top of the hairpin between
strands 3 and 4 and are essential for the CIDE-N/CIDE-N the other hand, once the death signal is received and
DFF45 is proteolysed by Caspase 3, it functions as aninteractions. Thus, these mutations should lead to the
activation of DFF40, as they are expected to disrupt the activator domain interacting with the catalytic domain
of DFF40 and triggering DNA degradation and chromatinDFF40/DFF45 complex. Nevertheless, both E50A and
D51A mutants exhibit reduced catalytic potency. To ad- condensation.
dress the mode of DFF40 activation, we have compared
the nuclease activity of these two mutants in a cell- Conclusion
CIDE-N domains are involved in the regulation of down-free system (Figure 6) with the wild-type enzyme in the
absence of DFF45. The levels of the enzyme have been stream events in apoptosis. Their homophilic interac-
tions have been shown to mediate proapoptotic activitycarefully normalized by Western blotting. Both mutants
Cell
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labeling of arginine were used to confirm the sequential assignmentof CIDE proteins, nuclease activity of DFF40, and inhibi-
of amide protons. Side chain proton resonances were mostly as-tory and chaperone activity of DFF45 (Inohara et al.,
signed using 3D Cbd-HCCH-TOCSY (Matsuo et al., 1997) and 3D1998, 1999; McCarty et al., 1999a, 1999b). We have de- 15N-dispersed TOCSY-HSQC spectra, recorded using uniformly
termined the three-dimensional structure of the CIDE-N 13C-labeled protein in D2O and uniformly 15N-labeled protein in H2O,
domain of the human CIDE-B protein. The structure con- respectively. The assignment of aromatic side chains was accom-
plished using homonuclear TOCSY and NOESY experiments, ac-sists of a five-stranded twisted b sheet and two a helices
quired on the nonlabeled protein in D2O. Stereo-specific assignmentwith a topology of an a/b roll. The interaction interfaces
of methyl groups of valine, isoleucine, and leucine was obtainedof the CIDE-N domain of CIDE-B with CIDE-N domains
from 13C-HSQC spectrum of a 10% 13C-labeled protein (Szypserskiof DFF40 and DFF45 have been found to be similar.
et al., 1992 ). 3JaN couplings were obtained through an HMQC-JThey have been mapped to the solvent-exposed face experiment (Bax et al., 1983).
of strands 1 and 2 and the conserved EDG loop residues
located on the same side of the CIDE-N domain of NMR Binding Studies of CIDE-N/CIDE-N Interaction
CIDE-Ns of CIDE-B, DFF40, and DFF45 were exchanged into NMRCIDE-B. This binding face is highly charged and consists
buffer before titration. A series of 1H-15N HSQC spectra were re-of two clusters of the opposite polarity. Homology mod-
corded by adding different amounts of nonlabeled CIDE-Ns ofeling of DFF40 and DFF45 using a segment matching
DFF40 and DFF45 into 100 mM 15N-labeled CIDE-N of CIDE-B. NMR
method (Levitt, 1992) has shown that this surface polar- samples were equilibrated at room temperature for at least 1 hr
ity is conserved among the CIDE-N domains. Based on before recording the NMR spectra.
NMR titration data and electrostatic potential maps, we
Structural Calculationpresent a general model for a CIDE-N/CIDE-N complex.
Interproton distance constraints were derived from NOESY cross-CIDE-N domains associate in a yin/yang-like orientation,
peak volumes, which were autocalibrated using the CALIBA modulewhich involves neutralization of two bipolar surfaces
included in the DYANA package (GuÈ ntert et al., 1997). Dihedral angle
and maximizes their surface complementarity. Finally, constraints were generated using HABAS based on 3JaN couplings
having compared CIDE-N/CIDE-N interaction with other and NOE patterns. Initial structures were generated using the pro-
homophilic interactions involved in the regulation of apo- gram DYANA starting from random conformations and refined using
simulated annealing protocol in X-PLOR. Loose hydrogen bond con-ptosis, we conclude that CIDE-N/CIDE-N represents a
straints were introduced at the late state of structural calculationnovel type of homophilic interaction which mediates
and based on the characteristic NOE patterns observed for a helixdownstream events of apoptosis.
b strand conformations. Of the 30 calculated structures, the 15 best
with no NOE violation .0.2 AÊ and no dihedral angle violations .5.08
Experimental Procedures were presented in Figure 2 and were used to generate the statistics
(Table 1). Figures were generated using MOLMOL program (Koradi
Overexpression and Purification of CIDE-N (CIDE-B) (1±116), et al., 1996).
CIDE-N (DFF40) (1±80), and CIDE-N (DFF45) (1±116)
The CIDE-N of human CIDE-B (1±116) (GenBank accession number DFF40 Enzymatic Assay and Inhibition Assay
AF190901) was subcloned into pET-15b vector using NcoI/NdeI re- Plasmid DNase assay was performed in 20 ml reactions containing
striction sites. CIDE-N (CIDE-B) was expressed in Escherichia coli 2 mg supercoiled maxiprep DNA in buffer A (100 mM KCl, 5 mM
as C-terminal His-tag fusion protein. The transformed cells were MgCl2, and 1 mg/ml BSA). DFF40 was diluted in buffer A containinggrown at 378C and induced with 1 mM IPTG in either LB media (for 50% glycerol and was added in 2.5 ml to the reaction (glycerol was
unlabeled protein) or M9-minimal media substituted with 15N-NH4Cl not found to substantially effect the DNase reaction at concentra-
(1 g/l) for 15N-labeled protein and 13C-glucose (2 g/l) for uniform 13C tions up to 20%). CIDE-N (DFF45) and CIDE-N (CIDE-B) were diluted
labeling. A 90% deuterated, uniformly 15N, 13C labeled protein was in buffer A and added in 5 ml. DFF40 (1 pmol) and effector proteins
prepared by growing the cells in 90% D2O supplemented with were preincubated 15 min at 378C prior to the addition of DNA. After
15N-NH4Cl and 13C-glucose. Selective labeling of valine, leucine, and 30 min incubation at 378C, DNA loading dye containing 50 mM EDTA
isoleucine was obtained by growing cells in M9 media with 100 mg/l was added and the DNA fragments separated on a 2% agarose gel
15N-labeled corresponding amino acid. Reverse labeling of arginine by electrophoresis for 10 min at 150 V.
was obtained by growing cells in M9 media substituted with
15N-NH4Cl (1 g/l) and addition of 100 mg/l of unlabeled arginine. 10% Acknowledgments13C labeled sample was obtained using M9 media (containing 2 g/l
glucose) supplemented with 0.2 g/l 13C-glucose.
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